In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Eargo onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

NasdaqGS:EAR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2023	41	-108	-76	-75	N/A
6/30/2023	41	-141	-76	-75	N/A
3/31/2023	40	-149	-121	-118	N/A
12/31/2022	37	-157	-120	-117	N/A
9/30/2022	34	-159	-145	-142	N/A
6/30/2022	4	-188	-154	-150	N/A
3/31/2022	19	-175	-114	-109	N/A
12/31/2021	32	-158	-103	-98	N/A
9/30/2021	44	-124	-65	-59	N/A
6/30/2021	85	-45	-47	-41	N/A
3/31/2021	79	-32	-31	-26	N/A
12/31/2020	69	-30	-31	-26	N/A
9/30/2020	57	-32	-35	-30	N/A
6/30/2020	47	-44	-40	-36	N/A
3/31/2020	38	-47	-43	-39	N/A
12/31/2019	33	-44	-43	-39	N/A
9/30/2019	30	-42	-41	-37	N/A
12/31/2018	23	-34	-30	-27	N/A
12/31/2017	7	-25	-15	-14	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van EAR boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van EAR naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van EAR naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van EAR naar verwachting sneller zal groeien dan de markt US.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van EAR naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van EAR naar verwachting over 3 jaar hoog zal zijn

Eargo Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target decreased to US$2.00

Price target decreased to US$2.00

Price target decreased to US$10.50

Eargo, Inc. Withdraws Financial Guidance for the Fiscal Year Ending December 31, 2021

Consensus forecasts updated

Eargo, Inc. Provides Financial Guidance for the Year 2021

Recent updates

Eargo Files Form 15

Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index

Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings

Eargo, Inc. Announces Chief Financial Officer Changes, Effective from January 5, 2024

Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. (NasdaqGS:EAR) for $13 million.

Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. (NasdaqGS:EAR) for $13 million.

Eargo, Inc. to Report Q1, 2023 Results on May 11, 2023

Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency Is Cured

Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES

Nasdaq Grants 180 Calendar Days to Eargo, Inc. to Regain Compliance

Less than half of directors are independent

Eargo, Inc. Announces Board Changes

Eargo, Inc. Announces the Appointment of Donald Spence to Its Board of Directors

Eargo, Inc. has completed a Follow-on Equity Offering in the amount of $187.5 million.

Independent Director exercised options to buy US$273k worth of stock.

Eargo Receives Non-Compliance Notice From Nasdaq

Eargo Receives a Non-Compliance Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC

Price target decreased to US$2.00

Third quarter 2022 earnings released: US$1.29 loss per share (vs US$2.02 loss in 3Q 2021)

Eargo, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Eargo: Straining To Be Heard

Eargo jumps 77% following FDA rule on OTC hearing aids

Price target decreased to US$2.00

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Eargo, Inc., Annual General Meeting, Oct 12, 2022

Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M

Eargo, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Eargo completes $100M senior secured convertible notes issuance

Eargo, Inc.(NasdaqGS:EAR) dropped from Russell 2000 Growth Index

Eargo Receives a Letter from the Nasdaq Stock Market

Eargo Announces Receipt of Nasdaq Non-Compliance Letter

Eargo, Inc. announced delayed 10-Q filing

Eargo, Inc. announced delayed annual 10-K filing

Eargo, Inc. Launches Eargo 6 with Sound Adjust for Effortless Hearing

Eargo: A Binary Play On Hearing Loss

Price target decreased to US$10.50

Eargo Receives Notice from Nasdaq Stating Non Compliance with Listing Rule 5250(C)(1)

Eargo Is A High Risk 'Option' With High Potential

Eargo, Inc. Withdraws Financial Guidance for the Fiscal Year Ending December 31, 2021

Independent Director notifies of intention to sell stock

Consensus forecasts updated

Second quarter 2021 earnings released: US$0.50 loss per share (vs US$24.11 loss in 2Q 2020)

Eargo, Inc. Provides Financial Guidance for the Year 2021

Independent Director Geoffrey Pardo has left the company

Eargo Launches Eargo 5 Hearing Aid with Sound Match™ Technology

An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued

Chief Financial Officer notifies of intention to sell stock

Eargo, Inc.(NasdaqGS:EAR) dropped from Russell 3000E Value Index

Independent Director Juliet Bakker has left the company

Consensus EPS estimates increase to -US$1.00

First quarter 2021 earnings released: US$3.56 loss per share (vs US$33.52 loss in 1Q 2020)

Eargo, Inc. Increases Earnings Guidance for Full Year 2021

Eargo: I Am Slowly Starting To Listen

Independent Director notifies of intention to sell stock

Full year 2020 earnings released: US$3.80 loss per share (vs US$57.82 loss in FY 2019)

Analysts update estimates

Revenue and earnings beat expectations

Full year 2020 earnings released: US$3.80 loss per share (vs US$57.82 loss in FY 2019)

Analysts update estimates

Eargo, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: US$70.31

New 90-day high: US$63.00

What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?

Eargo trades high afte hours on strong Q4 revenue, gross systems shipped

Eargo: A Word Of Caution

Third quarter 2020 earnings released: US$24.38 loss per share

Eargo, Inc. Provides Earnings Guidance for the Full Year 2020

Eargo beats on revenue

Eargo, Inc. to Report Q3, 2020 Results on Nov 19, 2020